Offering hope to lymphoma patients who have exhausted their treatment options, the Food and Drug Administration just approved a new drug which was based on an antibody developed at the Miller School of Medicine and has proven effective in recent clinical trials against Hodgkin’s lymphoma (HL) and anaplastic large cell lymphoma (ALCL) in patients for whom standard therapies failed.
UHealth-University of Miami Health System leaders and Miami Dolphins players and executives welcomed cyclists, media, and fans to Sun Life Stadium Friday for the official kick-off of the 2011 Dolphins Cycling Challenge.
When Robert Chambers became the first patient to receive a potential new bladder cancer therapy developed by Miller School Nobel laureate Andrew V. Schally, he was out of treatment options, and hope. But after his final dose of the promising drug, Chambers is feeling better.
Glen Barber, Ph.D., professor of medicine and associate director of basic research at Sylvester Comprehensive Cancer Center, has been named chairman of the Department of Cell Biology and Anatomy. The selection comes after an extensive search by W. Dalton Dietrich, Ph.D., senior associate dean for Discovery Science, and the Cell Biology Chair Search Committee, at the request of Pascal J. Goldschmidt, M.D., Senior Vice President for Medical Affairs and Dean of the Miller School.
Sylvester Comprehensive Cancer Center has partnered with the American Cancer Society to open a Cancer Resource Center for current patients, survivors and caregivers.
Hyundai Motor America and its Miami-Fort Lauderdale dealers have awarded John Goldberg, M.D., assistant professor of pediatrics, a $50,000 Hyundai Scholar grant to study the anti-leukemia properties of metformin, a commonly prescribed oral medication for diabetes, in combination with other drugs.